Abstract
AbstractRelapses arising from dormant liver-stage Plasmodium vivax parasites (hypnozoites) are a major cause of vivax malaria. However, in endemic areas, a recurrent blood-stage infection following treatment can be hypnozoite-derived (relapse), a blood-stage treatment failure (recrudescence), or a newly acquired infection (reinfection). Each of these requires a different prevention strategy, but it was not previously possible to distinguish between them reliably. We show that individual vivax malaria recurrences can be characterised probabilistically by combined modelling of time-to-event and genetic data within a framework incorporating identity-by-descent. Analysis of pooled patient data on 1441 recurrent P. vivax infections in 1299 patients on the Thailand–Myanmar border observed over 1000 patient follow-up years shows that, without primaquine radical curative treatment, 3 in 4 patients relapse. In contrast, after supervised high-dose primaquine only 1 in 40 relapse. In this region of frequent relapsing P. vivax, failure rates after supervised high-dose primaquine are significantly lower (∼3%) than estimated previously.
Funder
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Thailand Research Fund
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference44 articles.
1. Howes, R. E. et al. Global epidemiology of Plasmodium vivax. Am. J. Trop. Med. Hyg. 95, 15–34 (2016).
2. Coatney, G. R., Cooper, W. C. & Young, M. D. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J. Natl. Malar. Soc. 9, 381–96 (1950).
3. White, N. J. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar. J. 10, 297 (2011).
4. Battle, K. E. et al. Geographical variation in Plasmodium vivax relapse. Malar. J. 13, 144 (2014).
5. Recht, J., Ashley, E. & White, N. Safety of 8-Aminoquinoline Antimalarial Medicines (World Health Organization, 2014).
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献